The Innovative Combination of Hong Kong's Brand Strength and the Mainland's Advanced Manufacturing Technology in Developing the Greater Bay Area as a Centre of High-quality Proprietary Chinese Medicine | Public Policy Research (PPR) Funding Scheme, Hong Kong SAR Government | HK$565,892 | [Project No.: 2021.A4.073.

“The Innovative Combination of Hong Kong's Brand Strength and the Mainland's Advanced Manufacturing Technology in Developing the Greater Bay Area as a Centre of High-quality Proprietary Chinese Medicine”, under the Hong Kong Institute of Asia-Pacific Studies, The Chinese University of Hong Kong, HK$565,892 funded by the Public Policy Research (PPR) Funding Scheme, the Hong Kong SAR Government, for 12 months starting on 18 August 2021. [Project Number: 2021.A4.073.